News

January 22, 2020January 22, 2020

Pilot Study Participant Helping Test Exoskeleton Device for MS Therapy Encouraged by Results

News

Since being diagnosed with multiple sclerosis (MS) 20 years ago, Kathy Miska’s ability to walk has steadily worsened, especially in recent years. As a participant of a pilot study ... Read more

January 22, 2020January 22, 2020

Blood Fats Affect Artery Size in People with MS, Study Finds

News

A new study has found a link between the amount of fat in the blood and changes to the arteries surrounding the necks and skulls of people with multiple ... Read more

January 21, 2020January 21, 2020

Mayzent Approved in Europe as First Oral Treatment for Active Secondary Progressive MS

News, SPMS

The European Commission has approved Novartis‘s Mayzent (siponimod) as the first oral treatment for adults with active secondary progressive multiple sclerosis (SPMS). Active SPMS is defined by the presence of evident relapses or the ... Read more

January 21, 2020January 21, 2020

Endonovo Therapeutics Issued Broad US Patent Covering Electromagnetic Treatment for MS

News

The United States Patent and Trademark Office (USPTO) has issued a patent to Endonovo Therapeutics for Application No. 15/549,748, which covers the company’s technique and device for electromagnetic treatment ... Read more

January 20, 2020January 20, 2020

Clinical Trial of Rhythmic Sound in Walking Rehab for MS Planned, MedRhythms Says

News

MedRhythms is planning to soon open a pilot clinical trial to assess the safety and efficacy of its MR-004, its investigational product that uses rhythmic sounds to improve walking abilities ... Read more

January 20, 2020January 20, 2020

Being Bilingual May Help to Delay Cognitive Decline in MS, Study Suggests

News

An ability to speak more than one language may help to protect people with multiple sclerosis (MS) against the cognitive decline caused by the disease, new research suggests. The ... Read more

January 17, 2020January 17, 2020

CMSC Announces 4 Winners of Pilot Research Awards for 2019

News

The Consortium of Multiple Sclerosis Centers (CMSC) named four scientists the winners of its Pilot Research Award for 2019, given to support projects thought to advance the CMSC’s mission and improve ... Read more

January 17, 2020January 17, 2020

BioMed X, Merck Start Research Project for Autoimmune Diseases, Including MS

News

BioMed X announced a new collaboration with Merck to create a joint research group to investigate the role of the intestinal epithelial barrier in the development and progression of autoimmune diseases, ... Read more

January 16, 2020January 16, 2020

Magenta Therapeutics to Advance Safer Immune Reset Therapy for MS Stem Cell Transplant in 2020

News

Magenta Therapeutics will continue to advance its investigational conditioning therapy CD45-ADC for patients with autoimmune diseases undergoing stem cell transplants, the company highlighted in a progress report. CD45-ADC is a ... Read more

January 16, 2020January 16, 2020

Scottish Medicines Consortium Approves Ocrevus for Treating PPMS

News, Ocrevus

Ocrevus (ocrelizumab) has been approved in Scotland as a treatment for early, inflammatory primary progressive multiple sclerosis (PPMS). The Scottish Medicines Consortium (SMC) has advised that Ocrevus can be prescribed ... Read more

January 15, 2020January 15, 2020

Specific Changes in Vitamin D Receptor Protein Linked to MS Risk, Study Suggests

News

A risk of multiple sclerosis rises in people with specific variations in a protein, called the vitamin D receptor, that affects how this vitamin works and is metabolized in the ... Read more

January 15, 2020January 15, 2020

Almost Half of MS Patients Change or Stop DMT Due to High Financial Burden, Survey Shows

News

The high cost of disease-modifying therapies (DMTs) for multiple sclerosis (MS), and the challenging process of insurance approval, lead to treatment gaps or alterations, increased symptoms, and sacrifices in ... Read more

January 14, 2020January 14, 2020

New Mechanism Boosting Myelin Regeneration May Ease MS Symptoms, Mouse Study Shows

News

Blocking a protein called PAR1 may enhance the regeneration of myelin, the protective fatty layer that covers nerve fibers and is damaged in multiple sclerosis (MS), a mouse study shows. ... Read more

January 14, 2020January 14, 2020

MS Progression Affected by Degree of Relapse Recovery and Timing of DMT Use, Study Says

News

Recovering well after a first relapse and starting a disease-modifying therapy (DMT) immediately afterward considerably increases the likelihood of slowing progression in multiple sclerosis (MS), a study suggests. Its findings ... Read more

January 13, 2020January 13, 2020

First MS Patient Dosed in Phase 2 Trial of Potential Remyelinating Therapy CNM-Au8, Clene Announces

News

The first participant has been dosed in the Phase 2 REPAIR-MS clinical trial examining the effects of CNM-Au8, Clene Nanomedicine‘s investigational remyelinating therapy, on brain metabolism in people with multiple ... Read more

January 13, 2020January 13, 2020

MyHealthTeams, EMD Serono Launch Online Family Planning Resource Center for MS Patients

News

To empower and support prospective mothers with multiple sclerosis (MS), MyHealthTeams — a free social network for people with chronic medical conditions — and pharmaceutical EMD Serono have launched the ... Read more

January 10, 2020January 10, 2020

US Patent Issued for Anavex 2-73 for Treatment of Neurodevelopmental Disorders, Including MS

News

Anavex Life Sciences has received a U.S. patent covering the use of Anavex 2-73 (blarcamesine) for the treatment of several neurodegenerative and neurodevelopmental conditions, including multiple sclerosis (MS) and ... Read more

January 10, 2020January 10, 2020

Vitalis Plans to Launch Phase 3 Trial Testing VTS-72 as Treatment for RRMS-related Flushing

News

Vitalis will soon test VTS-72, a new formulation of fumarate and VTS-Aspirin, in a Phase 3 trial as a treatment for flushing — facial redness, itching or rash — ... Read more

January 9, 2020January 9, 2020

Weight Loss Diets Rare Among Obese MS Patients Despite Link to Disease Progression, Study Suggests

News

Despite the fact that being obese or overweight may worsen multiple sclerosis (MS) prognosis, people with the neurodegenerative disease are not more likely to adopt weight loss diets, a small ... Read more

January 9, 2020January 9, 2020

New Trial Compares Stem Cell Treatment to Available Therapies for Severe Relapsing MS

News

A new clinical trial is comparing the best available therapies to an experimental stem cell therapy to treat severe forms of relapsing multiple sclerosis (MS). At the moment, more ... Read more

January 8, 2020January 8, 2020

Using Interferon-beta While Pregnant Does Not Influence Child Size at Birth, MS Study Finds

News

Treatment with interferon-beta therapy during pregnancy in women with multiple sclerosis (MS) does not influence children’s gestational age, birth weight, length, or head size, researchers report. The study with those ... Read more

January 8, 2020January 8, 2020

Study Links FTO Gene Mutation to Obesity, Increased Disability in MS Patients

News

A common mutation in the fat-mass obesity (FTO) gene is associated with obesity and increased disability in people with multiple sclerosis (MS), according to a Kuwaiti study. The data, which ... Read more

January 7, 2020January 7, 2020

Probiotics Show Potential to Prevent, Delay Development of MS, Study Finds

News

Probiotics show potential to prevent and delay the development of multiple sclerosis (MS) by changing immune and inflammatory responses, according to a review study. Data further support the link ... Read more

January 7, 2020January 7, 2020

Impaired Prospective Memory Affects MS Patients’ Ability to Perform Everyday Tasks, Study Finds

News

Prospective memory — the ability to remember to carry out a future task — is significantly impaired in multiple sclerosis (MS) patients, and may contribute to worse cognitive performance ... Read more

January 6, 2020January 6, 2020

Language Classes Promote Brain Health and Life Quality in RRMS Patients, Study Finds

News

Learning a second language can bolster the health-related quality of life and mental well-being of people with multiple sclerosis (MS) by working to expand areas of the brain involved ... Read more

January 6, 2020January 6, 2020

Brain Regeneration Impaired in Progressive MS, Unaffected By DMTs, Study Reports

News

Regeneration in the brain is reduced in people with primary progressive multiple sclerosis (PPMS), but enhanced during disease activity in those with relapsing-remitting MS (RRMS), a study reports. The ... Read more

January 3, 2020January 3, 2020

Gabapentinoid Use to Control MS Pain Can Lead to Respiratory Problems, FDA Warns

News

Gabapentinoids — a class of therapies sometimes used off-label to help control pain in people with multiple sclerosis (MS) — can increase the risk of serious breathing problems, particularly ... Read more

January 3, 2020January 3, 2020

DMT Use Linked to Fewer Hospitalizations Among Adults with MS in Canadian Province

News

The growing reliance on disease-modifying therapies (DMTs) to treat people with multiple sclerosis (MS) has led to fewer hospitalizations but not a drop in the number of physician visits, a population ... Read more

January 2, 2020January 2, 2020

Use of DMTs Changing ‘Natural History’ of Relapsing MS, Study Says

News

People with relapsing multiple sclerosis (MS) have a better prognosis and a slower progression to disability since the introduction of disease-modifying treatments (DMTs) some 20 years ago, according to ... Read more

January 2, 2020January 3, 2020

Future MS Trials Should Focus on Patient Experience, Providing Long-term Data, Working Group Says

News

Trials testing new immunotherapies for multiple sclerosis (MS) should focus more on patients’ experiences and on symptoms relevant for them such as fatigue, depression, and cognitive difficulties, a German ... Read more

December 20, 2019January 8, 2020

Managing Money Difficult for MS Patients with Cognitive Problems and Depression, Study Says

News

Effective money management, critical to independent living, is particularly difficult for people whose multiple sclerosis (MS) affects executive thinking skills and who struggle with depression and anxiety, a study reports. The ... Read more

December 19, 2019December 19, 2019

MS Patients Largely Favor Blood Stem Cell Transplants But Lack Understanding, Survey Finds

News

Many multiple sclerosis (MS) patients consider autologous hematopoietic stem cell transplant (aHSCT) potentially effective in treating their disease, but most report needing more — and more reliable — information to ... Read more

December 19, 2019December 19, 2019

Treatment Begins in Part 2 of Trial of Software App Addressing Depression in MS, Pear Says

News

Pear Therapeutics announced that a first patient is being treated in Part 2 of its feasibility trial of Pear-006, a software application that, given along with a disease-modifying therapy, delivers ... Read more

December 18, 2019December 18, 2019

Timing Speed of Eye-to-Brain Signals May Be Way of Measuring Myelin Changes, Study Says

News

Measuring the speed of signals sent to the brain by nerves in the eye could help assess if remyelination is taking place, a study in cats suggests. Such measurements ... Read more

December 18, 2019December 18, 2019

BrainStorm Cell Therapeutics Wins 2020 ‘Buzz of BIO’ Award

News

For its promising investigational therapeutic approach to neurodegenerative diseases, including progressive multiple sclerosis (MS), BrainStorm Cell Therapeutics is the Buzz of BIO 2020 winner in the Public Therapeutic Biotech category. The ... Read more

December 17, 2019December 17, 2019

Gene Silencing in Paternal X Chromosome May Explain Higher Rate of MS in Women, Mouse Study Suggests

News

A cluster of immune-related genes located in the X chromosome are more active in the X chromosome inherited from the mother than in the one from the father, a ... Read more

December 17, 2019December 17, 2019

Einstein Researchers Receive Grant to Study Brain Activity Related to Fall Risk in MS Patients

News

A grant awarded recently by the National Institutes of Health (NIH) will fund research to explore how brain changes in multiple sclerosis (MS) patients affect mobility. The five-year grant (1R01NS109023-01A1), ... Read more

December 16, 2019December 16, 2019

Breastfeeding Protects Against Postpartum Relapses in Women with MS, Review Finds

News

Women who breastfeed have a lower rate of multiple sclerosis (MS) relapses in the postpartum period compared to those who do not breastfeed or supplement it with regular formula, ... Read more

December 13, 2019January 15, 2020

Sitting Less, Walking More May Be Feasible Way to Healthier Life with MS, Study Suggests

News

Small changes in daily activities, like sitting less and walking more, may be healthful for people with multiple sclerosis (MS) without the challenges of formal exercise. A new study, “Management ... Read more

Pin It on Pinterest